AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 152 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $143,000 | -96.2% | 38,771 | -89.6% | 0.02% | -94.8% |
| Q4 2015 | $3,783,000 | +50.4% | 374,591 | +102.5% | 0.41% | +68.2% |
| Q3 2015 | $2,515,000 | +328.4% | 184,947 | +497.5% | 0.24% | +324.6% |
| Q2 2015 | $587,000 | +1.0% | 30,951 | +11.5% | 0.06% | +3.6% |
| Q4 2014 | $581,000 | -82.3% | 27,750 | -72.9% | 0.06% | -78.8% |
| Q2 2014 | $3,286,000 | -12.5% | 102,410 | +25.9% | 0.26% | +4.4% |
| Q1 2014 | $3,755,000 | -50.7% | 81,319 | -24.3% | 0.25% | -31.1% |
| Q4 2013 | $7,622,000 | – | 107,415 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,637,455 | $42,852,000 | 9.04% |
| Broadfin Capital, LLC | 2,502,578 | $65,492,000 | 5.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $140,005,000 | 3.03% |
| HighVista Strategies LLC | 265,110 | $6,938,000 | 1.11% |
| Perceptive Advisors | 381,100 | $9,973,000 | 0.78% |
| Healthcare Value Capital, LLC | 25,000 | $654,000 | 0.71% |
| ADVENT INTERNATIONAL, L.P. | 347,001 | $9,081,000 | 0.70% |
| Birchview Capital, LP | 46,000 | $1,204,000 | 0.63% |
| NORTH TIDE CAPITAL, LLC | 300,000 | $7,851,000 | 0.59% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,323,633 | $60,809,000 | 0.35% |